Biocon’s fundraising is viewed positively to manage debt. Expert Nischal Maheshwari is optimistic about Biocon’s future, expecting earlier investments to yield returns. He also favors contract development and manufacturing firms like Laurus Labs. Maheshwari sees potential in banking, metals, and power sectors, particularly execution-focused players in power.
A record run! NSE IPO draws Rs 90,000 crore demand, takes subscription crown among India’s 5 largest offerings
NSE IPO GMP Live Updates: The Rs 22,561.57 crore public issue, the second-largest IPO in India by issue size after Hyundai Motor India, received bids